4//SEC Filing
Shafer Bradford J 4
Accession 0001179110-20-001208
CIK 0001583107other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:05 PM ET
Size
6.3 KB
Accession
0001179110-20-001208
Insider Transaction Report
Form 4
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
- Award
Ordinary Shares
2020-02-03+54,000→ 294,334 total - Award
Ordinary Shares
2020-02-03+65,000→ 240,334 total
Footnotes (1)
- [F1]On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On February 3, 2020, the performance conditions applicable to 54,000 shares were achieved and such shares will vest on February 20, 2021, subject to the reporting person's continued service.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001302448
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 7:05 PM ET
- Size
- 6.3 KB